A complete response in small cell carcinoma of the esophagus treated by S-1/cisplatin combined chemotherapy and radiotherapy

Journal of Gastrointestinal Cancer

Volumn 41, Issue 4, 2010, Pages 275-280

  Hiraki, Masatsugu ^a   Tanaka, Masayuki ^a   Sato, Seiji ^a   Kai, Keita ^a   Morito, Kiyoto ^a   Kobayashi, Kiichiro ^a   Noshiro, Hirokazu ^a   Tokunaga, Osamu ^a   Miyazaki, Kohji ^a  

^a SAGA UNIVERSITY   (Japan)

Author keywords

chemotherapy; cisplatin; esophageal cancer; radiotherapy; S 1; small cell carcinoma

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; CISPLATIN;

AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; ESOPHAGOSCOPY; ESOPHAGUS CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; RADIATION DOSE; SMALL CELL CARCINOMA; TREATMENT RESPONSE; TUMOR BIOPSY;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASTHMA; CARCINOMA, SMALL CELL; CISPLATIN; COMBINED MODALITY THERAPY; DIABETES MELLITUS; DRUG COMBINATIONS; ESOPHAGEAL NEOPLASMS; HUMANS; HYPERTENSION; MALE; NEOPLASM STAGING; OXONIC ACID; RADIOTHERAPY; REMISSION INDUCTION; TEGAFUR;

EID: 78649485281     PISSN: 19416628     EISSN: 19416636     Source Type: Journal    
DOI: 10.1007/s12029-010-9159-7     Document Type: Article

References (31)

1. A Jemal R Siegel E Ward Y Hao J Xu T Murray MJ Thun 2008 Cancer statistics, 2008 CA Cancer J Clin 58 71 96 10.3322/CA.2007.0010 10.3322/CA.2007.0010 18287387 (Pubitemid 351521864)
2. JP Yun MF Zhang JH Hou QH Tian J Fu XM Liang, et al. 2007 Primary small cell carcinoma of the esophagus: clinicopathological and immunohistoghemical features of 21 cases BMC Cancer 7 38 10.1186/1471-2407-7-38 10.1186/1471-2407-7- 38 17335582
3. K Nemoto HJ Zhao T Goto Y Ogawa Y Takai H Matsushita, et al. 2002 Radiation therapy for limited-stage small-cell esophageal cancer Am J Clin Oncol 25 404 407 10.1097/00000421-200208000-00017 10.1097/00000421-200208000-00017 12151974 (Pubitemid 34864038)
4. N Koide H Saito A Suzuki T Sato K Koiwai N Nakamura, et al. 2007 Clinicopathologic features and histochemical analyses of proliferative activity and angiogenesis in small cell carcinoma of the esophagus J Gastroenterol 42 932 938 10.1007/s00535-007-2114-0 10.1007/s00535-007-2114-0 18085349
5. KL Beyer JB Marshall AA Diaz-Arias TS Loy 1991 Primary small-cell carcinoma of the esophagus. Report of 11 cases and review of the literature J Clin Gastroenterol 13 135 141 1:STN:280:DyaK3M3jslSjuw%3D%3D 10.1097/00004836-199104000-00004 1851772
6. F Casas F Ferrer B Farrus J Gasals A Biete 1997 Primary small cell carcinoma of the esophagus: a review of the literature with emphasis on therapy and prognosis Cancer 80 1366 1372 10.1002/(SICI)1097-0142(19971015)80:8<1366: :AID-CNCR2>3.0.CO;2-D 1:STN:280:DyaK2svnvVWltg%3D%3D 10.1002/(SICI)1097- 0142(19971015)80:8<1366::AID-CNCR2>3.0.CO;2-D 9338459 (Pubitemid 27441009)
7. KL Sun J He GY Cheng LX Chai 2007 Management of primary small cell carcinoma of the esophagus Chin Med J (Engl) 120 355 358
8. H Yamashita K Nakagawa T Asari N Murakami H Igaki K Okuma, et al. 2009 Concurrent chemoradiation alone with curative intent for limited-disease small-cell esophageal cancer in nine Japanese patients Dis Esophagus 22 113 118 10.1111/j.1442-2050.2008.00863.x 1:STN:280:DC%2BD1M7msFWltA%3D%3D 10.1111/j.1442-2050.2008.00863.x 18847450
9. J Bennouna E Bardet P Deguiral JY Douillard 2000 Small cell carcinoma of the esophagus: analysis of 10 cases and review of the published data Am J Clin Oncol 23 455 459 10.1097/00000421-200010000-00005 1:STN:280: DC%2BD3cvovVGnsQ%3D%3D 11039503 (Pubitemid 32429120)
10. A Hosokawa Y Shimada Y Matsumura Y Yamada K Muro T Hamaguchi, et al. 2005 Small cell carcinoma of the esophagus. Analysis of 14 cases and literature review Hepatogastroenterology 52 1738 1741 16334769
11. E Hudson J Powell S Mukherjee TD Crosby AE Brewster TS Maughan, et al. 2007 Small cell oesophageal carcinoma: an institutional experience and review of the literature Br J Cancer 96 708 711 10.1038/sj.bjc.6603611 1:STN:280:DC%2BD2s7jvVemsA%3D%3D 10.1038/sj.bjc.6603611 17299393 (Pubitemid 46376619)
12. K Chin S Baba H Hosaka A Ishiyama N Mizunuma E Shinozaki, et al. 2008 Irinotecan plus cisplatin for therapy of small-cell carcinoma of the esophagus: report of 12 cases from single institution experience Jpn J Clin Ooncol 38 426 431 10.1093/jjco/hyn041 10.1093/jjco/hyn041 (Pubitemid 351965947)
13. M Matsuoka N Boku T Yoshino S Hironaka Y Onozawa A Fukutomi, et al. 2005 Small cell carcinoma of the esophagus responding to fourth-line chemotherapy with weekly paclitaxel Int J Clin Oncol 10 429 432 10.1007/s10147-005-0502-0 10.1007/s10147-005-0502-0 16369748 (Pubitemid 41821528)
14. F Bibeau MC Chateau M Guiu E Assenat D Azria R Lavaill, et al. 2008 Small cell carcinoma with concomitant adenocarcinoma arising in a Barett's oesophagus: report of a case with a favourable behaviour Virchows Arch 452 103 107 10.1007/s00428-007-0533-1 10.1007/s00428-007-0533-1 18008084
15. Sobin L, Gospodarowicz M, Wittekind C, editors (2009) TNM classification of malignant tumors, 7th edn. UICC International Union Against Cancer
16. U.S. Department of Health and Human Services (2009) Common terminology criteria for adverse event (CTCAE), version 4.0. National Institutes of Health, National Cancer Institute.
17. B Brenner MA Shah M Gonen DS Klimstra J Shia DP Kelsen 2004 Small-cell carcinoma of the gastrointestinal tract: a retrospective study of 64 cases Br J Cancer 90 1720 1726 10.1002/(SICI)1097-0142(20000115)88:2<262::AID- CNCR3>3.0.CO;2-K 1:STN:280:DC%2BD2czgsFWnsQ%3D%3D 15150595
18. CD Medgyesy RA Wolff JB Putnam Jr JA Ajani 2000 Small cell carcinoma of the esophagus: the University of Texas M. D. Anderson Cancer Center experience and literature review Cancer 88 262 267 1:STN:280:DC%2BD3c7gvVOgsw%3D%3D 10.1002/(SICI)1097-0142(20000115)88:2<262::AID-CNCR3>3.0.CO;2-K 10640955 (Pubitemid 30051807)
19. B Brenner LH Tang DS Klimstra DP Kelsen 2004 Small-cell carcinomas of the gastrointestinal tract: a review J Clin Oncol 22 2730 2739 10.1200/JCO.2004.09. 075 10.1200/JCO.2004.09.075 15226341 (Pubitemid 41103762)
20. K Takubo K Nakamura M Sawabe T Arai Y Esaki M Miyashita, et al. 1999 Primary undifferentiated small cell carcinoma of the esophagus Hum Pathol 30 216 221 10.1016/S0046-8177(99)90279-4 1:STN:280:DyaK1M7ltF2isg%3D%3D 10.1016/S0046-8177(99)90279-4 10029452 (Pubitemid 29086955)
21. KY Lam S Law PH Tung J Wong 2000 Esophageal small cell carcinomas: clinicopathologic parameters, p53 overexpression, proliferation marker, and their impact on pathogenesis Arch Pathol Lab Med 124 228 233 1:STN:280:DC%2BD3c7it1Wqtg%3D%3D 10656731
22. V Chow S Law KY Lam JM Luk J Wong 2001 Telomerase activity in small cell esophageal carcinoma Dis Esophagus 14 139 142 10.1046/j.1442-2050.2001.00172.x 1:STN:280:DC%2BD3MrgtlOkuw%3D%3D 10.1046/j.1442-2050.2001.00172.x 11553225 (Pubitemid 32951985)
23. PN Lara Jr R Natale J Crowley HJ Lenz MW Redman JE Carleton, et al. 2009 Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124 J Clin Oncol 27 2530 2535 10.1200/JCO.2008.20.1061 1:CAS:528:DC%2BD1MXmvVOhsbo%3D 10.1200/JCO.2008.20.1061 19349543
24. C Mascaux M Paesmans T Berghmans F Branle JJ Lafitte F Lemaitre, et al. 2000 A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis Lung Cancer 30 23 36 10.1016/S0169-5002(00)00127-6 1:STN:280:DC%2BD2MnmsFemtw%3D%3D 10.1016/S0169-5002(00)00127-6 11008007
25. T Shirasaka K Nakano T Takechi H Satake J Uchida A Fujioka, et al. 1996 Antitumor activity of 1 M tegafur-0.4 M 5-chloro-2,4-dihydroxypyridine-1 M potassium oxonate (S-1) against human colon carcinoma orthotopically implanted into nude rats Cancer Res 56 2602 2606 1:CAS:528:DyaK28XjtlCgurg%3D 8653704
26. W Koizumi S Tanabe K Saigenji A Ohtsu N Boku F Nagashima, et al. 2003 Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer Br J Cancer 89 2207 2212 10.1038/sj.bjc.6601413 1:CAS:528:DC%2BD3sXpvVShtbc%3D 10.1038/sj.bjc.6601413 14676796 (Pubitemid 38168001)
27. Y Sakaguchi A Kabashima K Okita Y Ojima S Yamamura T Nishizaki, et al. 2005 Long-term outcome of S-1 and cisplatin combination therapy in patients with advanced or recurrent gastric cancer Gastric Cancer 8 111 116 10.1007/s10120-004-0313-4 1:CAS:528:DC%2BD2MXjvVCnur4%3D 10.1007/s10120-004- 0313-4 15864718 (Pubitemid 40655520)
28. SH Cho HJ Shim SR Lee JS Ahn DH Yang YK Kim, et al. 2008 Concurrent chemoradiotherapy with S-1 and cicplatin in advanced esophageal cancer Dis Esophagus 21 697 703 10.1111/j.1442-2050.2008.00837.x 10.1111/j.1442-2050.2008. 00837.x 18522639
29. H Iwase T Indo M Shimada T Tsuzuki K Nakarai S Kaida, et al. 2004 Esophageal cancer with colonic metastasis successfully treated by chemoradiotherapy followed by chemotherapy with S-1 and cisplatin Int J Clin Oncol. 9 398 402 10.1007/s10147-004-0412-6 10.1007/s10147-004-0412-6 15549592 (Pubitemid 40012710)
30. M Hiraki S Yunotani R Noguchi Y Shinozaki H Tani M Sakai, et al. 2005 Recurrence of esophageal cancer treated by combination TS-1/CDDP therapy Jpn J Cancer Chemotherapy 32 219 221
31. L Zeng G Ou S Itasaka H Harada X Xie K Shibuya, et al. 2008 TS-1 enhances the effect of radiotherapy by suppressing radiation-induced hypoxia-inducible factor-1 activation and inducing endothelial cell apoptosis Cancer Sci 99 2327 2335 10.1111/j.1349-7006.2008.00943.x 1:CAS:528:DC%2BD1cXhsVKgtLnN 10.1111/j.1349-7006.2008.00943.x 18823375